Successful Treatment of Methimazole-Induced Severe Aplastic Anemia by Granulocyte Colony-Stimulating Factor, Methylprednisolone, and Cyclosporin
Author(s) -
Munehiro Honda
Publication year - 2011
Publication title -
isrn endocrinology
Language(s) - English
Resource type - Journals
eISSN - 2090-4649
pISSN - 2090-4630
DOI - 10.5402/2011/732623
Subject(s) - medicine , pancytopenia , aplastic anemia , breast cancer , gastroenterology , granulocyte colony stimulating factor , methylprednisolone , surgery , anemia , right breast , cancer , chemotherapy , bone marrow
A 52-year-old Japanese woman was examined because of general malaise, weight loss and a lump in her left breast. She was diagnosed with cancer of the left breast and Graves' disease, and was administered methimazole (MMI). A left mastectomy was performed for the breast cancer. She presented with a high fever and peripheral blood examination revealed a severe pancytopenia. She was diagnosed with severe aplastic anemia, and administered G-CSF, however, the treatment was unsuccessful. Thus, oral methyprednisolone and cyclosporin were added. There was a remarkable improvement in the peripheral blood count.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom